Working Healthcare · 2025-09-23 · 58 min
Join Working Healthcare host Meredith Hirsh for a high-velocity conversation with Elizabeth Chabe, CEO of High Touch Group and author of The Giant’s Ladder. With venture capital cooling and NIH funding uncertain, the episode maps how life sciences and diagnostics startups prove value fast without burning cash. Elizabeth breaks down the rare disease diagnostic odyssey and argues for incentives that reward earlier, accurate detection. You’ll get pragmatic go-to-market tactics for regulated launches - what evidence to build first, where to find real partners and how to earn a hospital pilot. Because investors need guardrails, the discussion lays out due diligence questions to fund genuine breakthroughs instead of the next Theranos. Along the way, the conversation navigates science storytelling mistakes, physician-founder paths and budget-smart ways to keep timelines realistic. Cue this episode to learn how to craft credible stories, win smart capital and bring trustworthy diagnostics to patients faster. Be innovative! Contact Meredith: Website: meredithhirsh.com Instagram: @workinghealthcare Facebook: WorkingHealthcare LinkedIn: @meredithfhirsh YouTube: @WorkingHealthcare
Ep. 115 - Rural Hospitals Are Vanishing - Tom Campanella Explains Why It Matters86 / 100
Ep. 109 - Downcodes, Takebacks and Timely Filing: How Payers Really Win (ft. Chris Acevedo)75 / 100
Ep. 108 - Where Did All the Doctors Go? A Surgeon and Medical School Dean on What We’re Losing (ft. Dr. Chad Perlyn)80 / 100
Ep. 107 - From War Zones to Break Rooms: What Healthcare Leaders Miss About Change (ft. Dr. Loubna Noureddin)75 / 100
Ep. 106 - Why Healthcare Keeps Saying No to Better Solutions (ft. Holley Miller)80 / 100